XML 44 R31.htm IDEA: XBRL DOCUMENT
v3.22.1

Revenue (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Revenue from Contract with Customer [Abstract] |
Ssdule of revenues |
|  | For the Years |
|  | Ended December 31, |
|  | 2021 |  |  | 2020 |
Domestic Pharmaceuticals |  | $ | 9,641,925 |  |  | $ | 9,132,216 |
Export Medical Test Kits |  |  | - |  |  |  | 1,734,233 |
|  | $ | 9,641,925 |  |  | $ | 10,866,449 |

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the capitalized costs of unproved properties and major development projects that are excluded from capitalized costs being amortized. This includes the total costs excluded and, at a minimum, these categories of costs: acquisition costs, exploration costs, development costs in the case of significant development projects, and capitalized interest. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 932 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-10(c)(7)(ii)) -URI http://asc.fasb.org/extlink&oid=123726172&loc=d3e511914-122862 + Details
Name: | us-gaap_ScheduleOfCapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration